Principal Financial Group
KYNB

Principal Financial Group’s Kyntra Bio KYNB Stock Holding History

Principal Financial Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-878
Closed -$51.6K – 2400
2024
Q1 		$51.6K Sell
878
-102
-10% -$4.39K ﹤0.01% 2340
2023
Q4 		$21.7K Sell
980
-49
-5% -$739 ﹤0.01% 2383
2023
Q3 		$22.2K Buy
1,029
+149
+17% +$5.85K ﹤0.01% 2410
2023
Q2 		$59.4K Sell
880
-55
-6% -$22.7K ﹤0.01% 2343
2023
Q1 		$436K Sell
935
-37
-4% -$19.6K ﹤0.01% 1998
2022
Q4 		$389K Buy
972
+49
+5% +$18.8K ﹤0.01% 2037
2022
Q3 		$300K Buy
923
+1
+0.1% +$322 ﹤0.01% 2079
2022
Q2 		$243K Sell
922
-98
-10% -$25K ﹤0.01% 2240
2022
Q1 		$306K Buy
1,020
+18
+2% +$6.28K ﹤0.01% 2235
2021
Q4 		$353K Sell
1,002
-407
-29% -$127K ﹤0.01% 2207
2021
Q3 		$360K Buy
1,409
+31
+2% +$11K ﹤0.01% 2260
2021
Q2 		$917K Sell
1,378
-12,211
-90% -$7.03M ﹤0.01% 2059
2021
Q1 		$11.8M Buy
13,589
+2,455
+22% +$2.61M 0.01% 1314
2020
Q4 		$10.3M Buy
11,134
+537
+5% +$564K 0.01% 1207
2020
Q3 		$10.9M Buy
10,597
+102
+1% +$110K 0.01% 1022
2020
Q2 		$10.6M Buy
10,495
+3,746
+56% +$3.48M 0.01% 1027
2020
Q1 		$5.86M Buy
6,749
+241
+4% +$240K 0.01% 1201
2019
Q4 		$6.98M Sell
6,508
-93
-1% -$94.9K 0.01% 1416
2019
Q3 		$6.1M Sell
6,601
-79
-1% -$86.8K 0.01% 1436
2019
Q2 		$7.54M Buy
6,680
+965
+17% +$1.06M 0.01% 1376
2019
Q1 		$7.76M Buy
5,715
+167
+3% +$226K 0.01% 1380
2018
Q4 		$6.42M Sell
5,548
-507
-8% -$570K 0.01% 1402
2018
Q3 		$9.2M Buy
6,055
+151
+3% +$233K 0.01% 1370
2018
Q2 		$9.24M Buy
5,904
+977
+20% +$1.27M 0.01% 1349
2018
Q1 		$5.69M Sell
4,927
-59
-1% -$77.7K 0.01% 1517
2017
Q4 		$5.91M Sell
4,986
-324
-6% -$406K 0.01% 1511
2017
Q3 		$7.14M Sell
5,310
-269
-5% -$283K 0.01% 1425
2017
Q2 		$4.5M Buy
5,579
+137
+3% +$95.4K ﹤0.01% 1579
2017
Q1 		$3.35M Buy
5,442
+20
+0.4% +$12.2K ﹤0.01% 1642
2016
Q4 		$2.9M Buy
5,422
+1,028
+23% +$513K ﹤0.01% 1659
2016
Q3 		$2.27M Buy
4,394
+468
+12% +$220K ﹤0.01% 1662
2016
Q2 		$1.61M Sell
3,926
-60
-2% -$27.5K ﹤0.01% 1693
2016
Q1 		$2.12M Sell
3,986
-364
-8% -$181K ﹤0.01% 1619
2015
Q4 		$3.31M Buy
4,350
+342
+9% +$227K ﹤0.01% 1521
2015
Q3 		$2.2M Buy
4,008
+931
+30% +$564K ﹤0.01% 1624
2015
Q2 		$1.81M Buy
3,077
+250
+9% +$145K ﹤0.01% 1704
2015
Q1 		$2.22M Sell
2,827
-1,245
-31% -$965K ﹤0.01% 1636
2014
Q4 		$2.78M Buy
+4,072
New +$2.62M ﹤0.01% 1608

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Principal Financial Group's KYNB Position: Q2 2024 in Review

Principal Financial Group sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 878 shares — an estimated $51.6K sold.

Principal Financial Group first reported a position in KYNB in Q4 2014 and held it in 38 quarters. The position peaked at $11.8M in Q1 2021. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • Principal Financial Group reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 878 Kyntra Bio shares in Q2 2024, an estimated $51.6K.
  • Principal Financial Group first reported a position in Kyntra Bio in Q4 2014 and held it in 38 quarters.
  • Principal Financial Group's Kyntra Bio position peaked at $11.8M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.